1-17 of 17
Knut Wendelin
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

CNS Irradiation in Adult De Novo B-Precursor ALL / Lbl: Results of the Randomized GMALL T rial 08/2013 Indicate Potential Antileukemic Efficacy

Nicola Goekbuget, Björn Steffen, Kathrin Nachtkamp, Boris Böll, Veit L. Buecklein, Christoph Faul, Jens Panse, Christoph Röllig, Folker Schneller, Bernd Spriewald, Matthias Stelljes, Max S. Topp, Andreas Viardot, Vladan Vucinic, Knut Wendelin, Monika Brüggemann, Monika Szczepanowski, Stefan Schwartz, Thomas Burmeister, Axel Benner, Nicholas Schreck, Lena Reiser, Hubert Serve, Walter Fiedler
Journal: Blood
Blood (2023) 142 (Supplement 1): 828.
https://doi.org/10.1182/blood-2023-179442
Published: 2023
Journal Articles

Results of the Risk-Adapted, MRD-Stratified GMALL Trial 08/2013 in 281 T-ALL / T-Lbl Patients: Excellent Outcome of Standard Risk Thymic T-ALL

Nicola Goekbuget, Walter Fiedler, Nael Alakel, Max S. Topp, Maher Hanoun, Björn Steffen, Ralph Wäsch, Andreas Viardot, Kathrin Nachtkamp, Matthias Stelljes, Hendrik Poeck, Vladan Vucinic, Boris Böll, Joachim Beck, Lars Fransecky, Knut Wendelin, Folker Schneller, Christoph Faul, Veit L Buecklein, Lena Reiser, Monika Brüggemann, Hubert Serve, Stefan Schwartz
Journal: Blood
Blood (2022) 140 (Supplement 1): 115–117.
https://doi.org/10.1182/blood-2022-158381
Published: 2022
Journal Articles

Immediate Allogeneic Hematopietic Stem Cell Transplantation for Patients with NPM1-Mutated AML in Molecular Relapse

Kerstin Schaefer-Eckart, Knut Wendelin, Sabine Dressler, Johannes Gärtner, Lisa Schneider, Christian Thiede
Journal: Blood
Blood (2021) 138 (Supplement 1): 2288.
https://doi.org/10.1182/blood-2021-146549
Published: 2021
Journal Articles

Gemtuzumab Ozogamicin Plus Midostaurin in Combination with Standard Intensive Induction Therapy in Newly Diagnosed AML: Results from a Phase-I Study

Christoph Röllig, Christoph Schliemann, Jan-Henrik Mikesch, Lars Fransecky, Claudia D. Baldus, Björn-Niklas Heydrich, Maher Hanoun, Richard Noppeney, Sebastian Scholl, Ulf Schnetzke, Kerstin Schäfer-Eckart, Knut Wendelin, Martin Wermke, Manja Reimann, Frank Fiebig, Theresa Kretschmann, Friedrich Stoelzel, Nael Alakel, Martin Bornhäuser
Journal: Blood
Blood (2021) 138 (Supplement 1): 2324.
https://doi.org/10.1182/blood-2021-150069
Published: 2021
Journal Articles

First Results of the Risk-Adapted, MRD-Stratified GMALL Trial 08/2013 in 705 Adults with Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma (ALL/LBL)

Nicola Goekbuget, Matthias Stelljes, Andreas Viardot, Kathrin Nachtkamp, Björn Steffen, Folker Schneller, Nael Alakel, Max Topp, Boris Böll, Christoph Faul, Karsten Spiekermann, Knut Wendelin, Maher Hanoun, Ralph Wäsch, Joachim Beck, Sonja Martin, Vladan Vucinic, Claudia D. Baldus, Monika Brüggemann, Thomas Burmeister, Heike Pfeifer, Stefan Schwartz, Lena Baumann, Diana Tichy, Hubert Serve, Walter Fiedler
Journal: Blood
Blood (2021) 138 (Supplement 1): 362.
https://doi.org/10.1182/blood-2021-146306
Published: 2021
Journal Articles

Interim Results of a Multicenter, Single-Arm Study to Assess Blinatumomab in Adult Patients (pts) with Minimal Residual Disease (MRD) of B-Precursor (BCP) Acute Lymphoblastic Leukemia (GMALL-MOLACT1-BLINA)

Nicola Goekbuget, MD, Wiba Keke Wermann, Stefan Schwartz, MD PhD, Andreas Hüttmann, MD, Christoph Faul, MD, Simon Raffel, MD, Andreas Viardot, Professor Dr, Walter Fiedler, MD, Nael Alakel, MD, Matthias Stelljes, MD, Marion Subklewe, MD, Ralph Wäsch, Sonja Martin, MD, Wolfram Jung, MD, Vladan Vucinic, MD, Mustafa Kondakci, MD, Lars R. Fransecky, MD, Daniela Heidenreich, MD, Knut Wendelin, MD, Julian Hermann, Hubert Serve, MD PhD, Ralf C Bargou, MD PhD, Max S. Topp, MD, Monika Brüggemann, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 39–40.
https://doi.org/10.1182/blood-2020-137350
Published: 2020
Journal Articles

Nilotinib (Tasigna ® ) and Low Intensity Chemotherapy for First-Line Treatment of Elderly Patients with BCR-ABL1- Positive Acute Lymphoblastic Leukemia: Final Results of a Prospective Multicenter Trial (EWALL-PH02)

Oliver G. Ottmann, MD, Heike Pfeifer, MD, Jean-Michel Cayuela, PhD, Karsten Spiekermann, MD, Wolfram Jung, MD, Joachim Beck, Emmanuel Raffoux, MD, Pascal Turlure, MD, Chantal Himberlin, Francoise Huguet, MD, Andreas Viardot, MD, Knut Wendelin, MD, Albrecht Reichle, MD, Sébastien Maury, MD PhD, Laurence Sanhes, MD, Francoise Isnard, PhD, Jean-Yves Cahn, MD, Stephane Lepretre, Patrice Chevallier, MD, Martine Escoffre-Barbe, MD, Josep-Maria Ribera, MD PhD, Dieter Hoelzer, MD PhD, Nicola Goekbuget, MD, Hervé Dombret, Philippe Rousselot, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 31.
https://doi.org/10.1182/blood-2018-99-114552
Published: 2018
Journal Articles

Evaluation of Minimal Residual Disease (MRD) and MRD-Based Treatment Decisions in Ph/BCR-ABL Negative Adult Acute Lymphoblastic Leukemia (ALL): Experience from the German Multicenter Study Group for Adult ALL (GMALL)

Nicola Goekbuget, MD, Monika Brüggemann, Joachim Beck, MD, Christoph Faul, MD, Christian Koenecke, MD, Heinz A. Horst, MD PhD, Mustafa Kondakci, MD, Doris M. Kraemer, MD, PhD, Christoph Lutz, MD, Bernd Spriewald, MD, Michael Starck, MD, Christoph Rollig, MD MSC, Matthias Stelljes, MD, Andreas Viardot, MD, Ralph Wäsch, Knut Wendelin, MD, Hubert Serve, Michael Kneba, MD, Dieter Hoelzer, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 139.
https://doi.org/10.1182/blood.V130.Suppl_1.139.139
Published: 2017
Journal Articles

Early Allogeneic Blood Stem Cell Transplantation after Melphalan-Induced Aplasia for Patients with Primary Refractory or Relapsed Acute Myeloid Leukemia - Results of a Retrospective Single Center Analysis

Kerstin Schaefer-Eckart, MD, Knut Wendelin, MD, Sabine Dressler, MD, Starke Martina, MD, Martin Wilhelm, MD PhD
Journal: Blood
Blood (2016) 128 (22): 5839.
https://doi.org/10.1182/blood.V128.22.5839.5839
Published: 2016
Journal Articles

Consolidation Therapy Is Associated with Significantly Lower Bleeding Risk Compared to Induction Therapy in Patients with Acute Myeloid Leukemia

Kerstin Schaefer-Eckart, MD, Knut Wendelin, MD, Bettina Pilz, Michael Kramer, PhD, Gerhard Ehninger, MD, Martin Wilhelm, MD PhD, Hannes Wandt, MD
Journal: Blood
Blood (2014) 124 (21): 3686.
https://doi.org/10.1182/blood.V124.21.3686.3686
Published: 2014
Journal Articles

Significant Improvement Of Outcome In Adolescents and Young adults (AYAs) Aged 15-35 Years With Acute Lymphoblastic Leukemia (ALL) With a Pediatric Derived Adult ALL Protocol; Results Of 1529 AYAs In 2 Consecutive Trials Of The German Multicenter Study Group For Adult ALL (GMALL)

Nicola Gökbuget, MD, Joachim Beck, MD, Kalina Brandt, Monika Brüggemann, MD, Thomas Burmeister, MD, Helmut Diedrich, Christoph Faul, MD, Andreas Hüttmann, Mustafa Kondakci, MD, Doris M Kraemer, M.D., Oliver G. Ottmann, MD, Stefan Schwartz, MD, Hubert Serve, MD, Michael Starck, MD, Matthias Stelljes, MD, Reingard Stuhlmann, MD, Andreas Viardot, Ralph M. Waesch, MD, Knut Wendelin, MD, Dietrich Beelen, MD, Renate Arnold, MD, Dieter Hoelzer, MD
Journal: Blood
Blood (2013) 122 (21): 839.
https://doi.org/10.1182/blood.V122.21.839.839
Published: 2013
Journal Articles

Moderate Intensive Chemotherapy Including CNS-Prophylaxis with Liposomal Cytarabine Is Feasible and effective in Older Patients with Ph-Negative Acute Lymphoblastic Leukemia (ALL): Results of a Prospective Trial From the German Multicenter Study Group for Adult ALL (GMALL)

Nicola Goekbuget, MD, Joachim Beck, MD, Monika Brueggemann, Thomas Burmeister, MD, Eike C. Buss, MD, Norbert Frickhofen, MD, Andreas Huettmann, MD, Anke Morgner, MD, Albrecht Reichle, Ingo Schmidt-Wolf, MD, Stefan Schwartz, MD, Hubert Serve, Prof. Dr. med., Bernd M Spriewald, MD, Michael Starck, MD, Matthias Stelljes, MD, Andreas Viardot, MD, Knut Wendelin, MD, Dieter Hoelzer, MD
Journal: Blood
Blood (2012) 120 (21): 1493.
https://doi.org/10.1182/blood.V120.21.1493.1493
Published: 2012
Journal Articles

Long Term Follow-up of 121 Elderly Patients with Philadelphia-Positive Acute Lymphoblastic Leukaemia (Ph+ALL) Treated in Prospective GMALL Trials Supports a Greater Emphasis On Allogeneic SCT as Definitive Postremission Therapy.

Heike Pfeifer, MD, Christoph Wettner, Barbara Wassmann, Aristoteles A.N. Giagounidis, Matthias Stelljes, MD, Ulrich Duehrsen, MD, Marc Schmalzing, MD, Markus Schaich, MD, Maike De Wit, Arnold Ganser, Winfried Gassmann, MD, PhD, Michael Pfreundschuh, MD, Nicolai Haertel, Knut Wendelin, MD, Mathias Schmid, MD, Hans Joachim Beck, Jolanta Dengler, MD, Heinz-August Horst, MD, Michael Lübbert, MD, Hubert Serve, Prof. Dr. med., Nicola Goekbuget, MD, Dieter Hoelzer, MD, Oliver G. Ottmann, MD
Journal: Blood
Blood (2012) 120 (21): 2608.
https://doi.org/10.1182/blood.V120.21.2608.2608
Published: 2012
Journal Articles

Outcome of relapsed adult lymphoblastic leukemia depends on response to salvage chemotherapy, prognostic factors, and performance of stem cell transplantation

Clinical Trials & Observations
Nicola Gökbuget, Daniel Stanze, Joachim Beck, Helmut Diedrich, Heinz-August Horst, Andreas Hüttmann, Guido Kobbe, Karl-Anton Kreuzer, Lothar Leimer, Albrecht Reichle, Markus Schaich, Stefan Schwartz, Hubert Serve, Michael Starck, Matthias Stelljes, Reingard Stuhlmann, Andreas Viardot, Knut Wendelin, Mathias Freund, Dieter Hoelzer
Journal: Blood
Blood (2012) 120 (10): 2032–2041.
https://doi.org/10.1182/blood-2011-12-399287
Published: 2012
Includes: Supplemental data
Journal Articles

Successful Subtype Oriented Treatment Strategies in Adult T-All; Results of 744 Patients Treated in Three Consecutive GMALL Studies.

Dieter Hoelzer, MD, PhD, Eckhard Thiel, Renate Arnold, MD, Joachim Beck, MD, Dietrich W. Beelen, MD, PhD, Martin Bornhäuser, MD, Donald Bunjes, MD, Diana Ditz, MD, Ulrich Dührsen, MD, PhD, Jörg Finke, MD, Heinz A Horst, MD, Guido Kobbe, MD, Hans Jochem Kolb, MD, PhD, Karl Anton Kreuzer, MD, Nicolaus Kröger, MD, Thomas Lipp, MD, Markus Schaich, MD, Mathias Schmid, MD, Stefan Schwartz, MD, Rainer Schwerdtfeger, MD, Hubert Serve, MD, PhD, Reingard Stuhlmann, MD, Knut Wendelin, MD, Christof Scheid, Nicola Gökbuget, MD
Journal: Blood
Blood (2009) 114 (22): 324.
https://doi.org/10.1182/blood.V114.22.324.324
Published: 2009
Journal Articles

A Therapeutic Platelet Transfusion Strategy without Routine Prophylactic Transfusion Is Feasible and Safe and Reduces Platelet Transfusion Numbers Significantly: Preliminary Analysis of a Randomized Study in Patients after High Dose Chemotherapy and Autologous Peripheral Blood Stem Cell Transplantation

Hannes Wandt, MD, Knut Wendelin, MD, Kerstin Schaefer-Eckart, MD, Markus Thalheimer, MD, Mario Stephan Schubert, MD, Roland Conradi, MD, Rainer Schwerdtfeger, MD, Lothar Leimer, MD, Martin Kaufmann, MD, Gottfried Dölken, MD, Anne Friederike Klenner, MD, Markus Schaich, MD, Gerhard Ehninger, MD
Journal: Blood
Blood (2008) 112 (11): 286.
https://doi.org/10.1182/blood.V112.11.286.286
Published: 2008
Journal Articles

Interim Analysis of a Prospective Randomised Study Comparing a Therapeutic Platelet Transfusion Strategy with the Prophylactic Platelet Transfusion Standard in Patients after Autologous Peripheral Stem Cell Transplantation (ASCT).

Kerstin Schaefer-Eckart, MD, Knut Wendelin, MD, Martin Wilhelm, MD, PhD, U. Mahlknecht, MD, R. Conradi, MD, M. Schaich, MD, L. Leimer, MD, Hannes Wandt, MD
Journal: Blood
Blood (2006) 108 (11): 577.
https://doi.org/10.1182/blood.V108.11.577.577
Published: 2006